![]() |
![]() |
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
(51) | INT.CL. | A61K 31/506 | (2006.01) |
A61K 45/00 | (2013.01) | ||
A61P 11/00 | (2006.01) | ||
A61K 31/506 | (2013.01) |
(11) | Patento numeris | 3920970 |
(13) | Dokumento rūšis | T |
(96) | Europos patento paraiškos numeris | 20702304.5 |
Europos patento paraiškos padavimo data | 2020-02-03 | |
(97) | Europos patento paraiškos paskelbimo data | 2021-12-15 |
(45) | Paskelbimo apie Europos patento išdavimą data | 2022-11-23 |
(46) | Apibrėžties vertimo paskelbimo data |
(86) | Numeris | PCT/EP2020/052554 |
Data | 2020-02-03 |
(87) | Numeris | WO 2020/161045 |
Data | 2020-08-13 |
(30) | Numeris | Data | Šalis |
19305128 | 2019-02-04 | EP |
(72) |
SALEM, Joe-Elie , FR
ALLENBACH, Yves , FR
KERNEIS, Mathieu , FR
MOSLEHI, Javid , US
JOHNSON, Douglas , US
|
(73) |
Assistance Publique Hôpitaux de Paris ,
55 boulevard Diderot, 75012 Paris,
FR
Sorbonne Université , 21 Rue de l'Ecole de Médecine, 75006 Paris, FR Institut National de la Santé et de la Recherche Médicale (INSERM) , 101 rue de Tolbiac, 75013 Paris, FR Vanderbilt University , 305 Kirkland Hall 2201 West End Avenue, Nashville, TN 37240, US |
(54) | METHOD FOR TREATING CHECKPOINT INHIBITORS INDUCED ADVERSE EVENTS |
METHOD FOR TREATING CHECKPOINT INHIBITORS INDUCED ADVERSE EVENTS |